1. Lim MY, Foster J, Greenberg CS (2017) Initial and long term impact of a multi-disciplinary task force in the diagnosis and management of heparin-induced thrombocytopenia. J Thromb Thrombolysis.
https://doi.org/10.1007/s11239-017-1592-z
2. Pierce W, Mazur J, Greenberg C, Mueller J, Foster J, Lazarchick J (2013) Evaluation of heparin-induced thrombocytopenia (HIT) laboratory testing and the 4Ts scoring system in the intensive care unit. Ann Clin Lab Sci 43:429–435
3. Mattioli AV, Bonetti L, Sternieri S, Mattioli G (2000) Heparin-induced thrombocytopenia in patients treated with unfractionated heparin: prevalence of thrombosis in a 1 year follow-up. Ital Heart J 1:39–42
4. Warkentin TE, Heddle NM (2003) Laboratory diagnosis of immune heparin-induced thrombocytopenia. Curr Hematol Rep 2:148–157
5. Mattioli AV, Bonetti L, Carletti U, Ambrosio G, Mattioli G (2009) Thrombotic events in patients with antiplatelet factor 4/heparin antibodies. Heart 95(16):1350–1354.
https://doi.org/10.1136/hrt.2008.160549